UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Development of opioid analgesic tolerance in rat to extended-release buprenorphine formulated for laboratory subjects

PloS one, 2024-03, Vol.19 (3), p.e0298819-e0298819

2024

Volltextzugriff (PDF)

Targeting the somatosensory system with AAV9 and AAV2retro viral vectors

PloS one, 2022-03, Vol.17 (3), p.e0264938-e0264938

2022

Volltextzugriff (PDF)

Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice

Anesthesiology (Philadelphia), 2019-09, Vol.131 (3), p.649-663

2019

Volltextzugriff (PDF)

Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer

Human gene therapy, 2017-08, Vol.28 (8), p.626

2017

Volltextzugriff (PDF)

Effect of chronic pain on fentanyl self-administration in mice

PloS one, 2013-11, Vol.8 (11), p.e79239-e79239

2013

Volltextzugriff (PDF)

Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse

Frontiers in neuroanatomy, 2014-06, Vol.8, p.42-42

2014

Volltextzugriff (PDF)

Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I

Frontiers in molecular neuroscience, 2021-05, Vol.14, p.618360-618360

2021

Volltextzugriff (PDF)

Differential Adeno-Associated Virus Mediated Gene Transfer to Sensory Neurons following Intrathecal Delivery by Direct Lumbar Puncture

Molecular pain, 2010-05, Vol.6 (1), p.31-31

2010

Volltextzugriff (PDF)

Comparative dose effectiveness of intravenous and intrathecal AAV9.CB7.hIDS, RGX-121, in mucopolysaccharidosis type II mice

Molecular therapy. Methods & clinical development, 2024-03, Vol.32 (1), p.101201-101201, Article 101201

2024

Volltextzugriff (PDF)

AAV-mediated gene transfer to colon-innervating primary afferent neurons

Frontiers in pain research (Lausanne, Switzerland), 2023-08, Vol.4, p.1225246

2023

Volltextzugriff (PDF)

Characterization of Novel, Agmatine‐Based NMDA Receptor Antagonists in Multiple Pain States

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

Adeno-associated virus-mediated gene transfer of arginine decarboxylase to the central nervous system prevents opioid analgesic tolerance

Frontiers in pain research (Lausanne, Switzerland), 2023, Vol.4, p.1269017-1269017

2023

Volltextzugriff (PDF)

Proteomic Analysis Uncovers Novel Actions of the Neurosecretory Protein VGF in Nociceptive Processing

The Journal of neuroscience, 2009-10, Vol.29 (42), p.13377-13388

2009

Volltextzugriff (PDF)

Supraspinal gene transfer by intrathecal adeno-associated virus serotype 5

Frontiers in neuroanatomy, 2014-08, Vol.8, p.66-66

2014

Volltextzugriff (PDF)

Strategically Substituted Agmatine Analogs Reduce Neuropathic Pain and Show Improved Pharmacokinetics Compared to Agmatine

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse

The Journal of pharmacology and experimental therapeutics, 2005-09, Vol.314 (3), p.1226

2005

Volltextzugriff (PDF)

Clonidine and Dexmedetomidine Produce Antinociceptive Synergy in Mouse Spinal Cord

Anesthesiology (Philadelphia), 2009-03, Vol.110 (3), p.638-647

2009

Volltextzugriff (PDF)

Central Nervous System Distribution of an Opioid Agonist Combination with Synergistic Activity

The Journal of pharmacology and experimental therapeutics, 2022-01, Vol.380 (1), p.34

2022

Volltextzugriff (PDF)

Sustained-release buprenorphine induces acute opioid tolerance in the mouse

European journal of pharmacology, 2020-10, Vol.885, p.173330, Article 173330

2020

Volltextzugriff (PDF)

Long-term reversal of chronic pain behavior in rodents through elevation of spinal agmatine

Molecular therapy, 2023-04, Vol.31 (4), p.1123-1135

2023

Volltextzugriff (PDF)

Agmatine requires GluN2B-containing NMDA receptors to inhibit the development of neuropathic pain

Molecular pain, 2021, Vol.17, p.17448069211029171-17448069211029171

2021

Volltextzugriff (PDF)

Bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice

Pain (Amsterdam), 2017-12, Vol.158 (12), p.2431-2441

2017

Volltextzugriff (PDF)

AAV-Mediated Gene Delivery to the Enteric Nervous System by Intracolonic Injection

Methods in molecular biology (Clifton, N.J.), 2019, Vol.1950, p.407

2019

Volltextzugriff (PDF)

Biodistribution of Adeno-Associated Virus Serotype 5 Viral Vectors Following Intrathecal Injection

Molecular pharmaceutics, 2021-10, Vol.18 (10), p.3741-3749

2021

Volltextzugriff (PDF)

Involvement of the VGF-derived peptide TLQP-62 in nerve injury-induced hypersensitivity and spinal neuroplasticity

Pain (Amsterdam), 2018-09, Vol.159 (9), p.1802-1813

2018

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of opioid analgesic tolerance in rat to extended-release buprenorphine formulated for laboratory subjects

Targeting the somatosensory system with AAV9 and AAV2retro viral vectors

Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice

Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer

Effect of chronic pain on fentanyl self-administration in mice

Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse

Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I

Differential Adeno-Associated Virus Mediated Gene Transfer to Sensory Neurons following Intrathecal Delivery by Direct Lumbar Puncture

Comparative dose effectiveness of intravenous and intrathecal AAV9.CB7.hIDS, RGX-121, in mucopolysaccharidosis type II mice

AAV-mediated gene transfer to colon-innervating primary afferent neurons

Characterization of Novel, Agmatine‐Based NMDA Receptor Antagonists in Multiple Pain States

Adeno-associated virus-mediated gene transfer of arginine decarboxylase to the central nervous system prevents opioid analgesic tolerance

Proteomic Analysis Uncovers Novel Actions of the Neurosecretory Protein VGF in Nociceptive Processing

Supraspinal gene transfer by intrathecal adeno-associated virus serotype 5

Strategically Substituted Agmatine Analogs Reduce Neuropathic Pain and Show Improved Pharmacokinetics Compared to Agmatine

Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse

Clonidine and Dexmedetomidine Produce Antinociceptive Synergy in Mouse Spinal Cord

Central Nervous System Distribution of an Opioid Agonist Combination with Synergistic Activity

Sustained-release buprenorphine induces acute opioid tolerance in the mouse

Long-term reversal of chronic pain behavior in rodents through elevation of spinal agmatine

Agmatine requires GluN2B-containing NMDA receptors to inhibit the development of neuropathic pain

Bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice

AAV-Mediated Gene Delivery to the Enteric Nervous System by Intracolonic Injection

Biodistribution of Adeno-Associated Virus Serotype 5 Viral Vectors Following Intrathecal Injection

Involvement of the VGF-derived peptide TLQP-62 in nerve injury-induced hypersensitivity and spinal neuroplasticity

Suchergebnisse filtern